The brand new device is very much more than a monitor. It will make real time patient data accessible by both Alere nurse treatment managers and attending doctors. The connectivity and simplicity will make risk assessment, previously risk identification, and triage for individuals with high-risk pregnancy conditions possible for the first time in a radio, same-time environment. The reporting capabilities with the AN24 include the ability to extract crucial parameters from fetal heartrate and uterine activity traces, which will trigger immediate contact from an Alere nurse care manager in coordination with pharmacists or physicians as necessary. Importantly, the new technology can make it easy for nurse care managers to electronically send messages with key improvements and specific education direct to the patient.Presently in the pipeline are an inactivated virus vaccine comparable to effective vaccines against other viruses, along with vector-based, recombinant and DNA-structured vaccines. A SARS vaccine may well be in the offing. Related StoriesKey part of MRSA vaccine puzzle unearthedMany seasonal allergy victims take OTC items rather prescription medicationsLess effective medicines might help beat malaria even more effectivelyDengue provides been on the rise since World Battle II. Today, more than 2.5 million people are at risk for the condition because they live in areas infested with dengue’s mosquito vector.